MedTrace Logo

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

NCT05610592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2022-11-09

No results posted yet for this study

Summary

This study investigates the ability of tumor budding to identify prognosis in different MMR states and different levels of tumor lymphocyte infiltration. Tumor budding is usually defined as an isolated single cancer cell or a cluster of up to four cancer cells located at the front of an infiltrating tumor.

Conditions

Interventions

PROCEDURE

total mesorectal exicision

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05610592 on ClinicalTrials.gov